January 30, 2015 7:16 AM ET

Healthcare Equipment and Supplies

Company Overview of Integrated Diagnostics Inc.

Company Overview

Integrated Diagnostics Inc. engages in developing and creating laboratory-developed blood-based molecular diagnostics tools that assist physicians with the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer by simultaneously monitoring disease molecular markers. It offers Xpresys Lung, a molecular blood test to provide non-invasive objective information for the assessment of pulmonary nodules. Integrated Diagnostics Inc. has a strategic partnership with Agilent Technologies Inc. The company was formerly known as Homestead Clinical Corporation. Integrated Diagnostics Inc. was founded in 2005 and is based in Seattle, Washington.

219 Terry Avenue North

Suite 100

Seattle, WA 98109-5208

United States

Founded in 2005





Key Executives for Integrated Diagnostics Inc.

Chief Executive Officer and Board Member
Age: 65
Co- Founder
Co-Founder and Director
Age: 75
Co-Founder and Scientific Advisor
Co-Founder and Board Member
Age: 53
Compensation as of Fiscal Year 2014.

Integrated Diagnostics Inc. Key Developments

Integrated Diagnostics Appoints Douglas Sanders as Chief Financial Officer

Integrated Diagnostics appointed Douglas Sanders as chief financial officer. Sanders is a prominent international life sciences CFO and entrepreneur who most recently served as CFO of CMC Biologics. In addition to his leadership role at CMC Biologics, Sanders is the co-founder of several life sciences companies. Prior to that, he spent 15 years with Hoffmann-La Roche, mainly in Europe. His most recent position at Roche was as head of business operations and CFO for Roche Consumer Health, a division of Hoffmann-La Roche based in Switzerland.

Integrated Diagnostics Secures Contracts for Xpresys(R) Lung With Multiplan and Five Other PPOs

Integrated Diagnostics announced that it has secured contractual agreements with MultiPlan and five other PPOs (preferred provider organizations) for Xpresys(R) Lung, the first non-invasive molecular blood test for the assessment of pulmonary nodules. The other PPOs are: FedMed, Fortified Provider Network, InterWest Health, Stratose, and Three Rivers Provider Network. Together, these managed care organizations provide access to more than 130 million insured lives; combined with Indi's existing commercial insurance contracts the test is now available to well over 200 million insured lives. Xpresys Lung is a breakthrough protein expression blood test developed to provide physicians with a solution to a major medical dilemma in the United States -- the overtreatment of benign lung nodules. Xpresys Lung provides physicians with objective information to identify nodules with a high probability of being benign, potentially reducing unnecessary invasive procedures which may be risky for the patient and costly to the healthcare system.

Integrated Diagnostics Inc. Presents at Baird's 2014 Healthcare Conference, Sep-04-2014 11:25 AM

Integrated Diagnostics Inc. Presents at Baird's 2014 Healthcare Conference, Sep-04-2014 11:25 AM. Venue: The New York Palace, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
PendoTECH United States
WHILL, Inc. United States
RetinaLabs.com, Inc. United States
CareFusion 202, Inc. United States
Carticept Medical, Inc. United States

Recent Private Companies Transactions

Private Placement
April 25, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Integrated Diagnostics Inc., please visit www.indidx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.